Interestingly, other glutamate transporters such as EAAT1 and EAAT2 are silenced in brain cancer and high abundant system Xc- (xCT) activity results in a net balance shift towards extracellular glutamate release. This evidence concerns the gene SLC1A3 and brain cancer.